1. Al-Sarraf M, Fletcher W, Oishi N, Pugh R, Hewlett JS (1987) Cisplatin hydration with and without mannitol diuresis in refractory disseminated malignant melanoma: a Southwest Oncology Group study. Cancer Treat Rep 66: 31?35
2. Ashraf M, Scotchel PL, Krall JM, Flink EB (1983)cis-Platinum-induced hypomagnesemia and peripheral neuropathy. Gynecol Oncol 16: 309?318
3. Bellet RE, Mastrangelo MJ, Laucius JF, Frederick J, Bodurtha, Audley J (1976) Randomized prospective trial of DTIC (NSC-45388) alone versus BCNU (NSC-409962) plus vincristine in the treatment of metastatic melanoma. Cancer Treat Rep 60: 595?600
4. Bruckner HW, Wallach R, Cohen CJ, Deppe G, Kabakon B, Ratner L, Holland JF (1981) High-dose platinum for the treatment of refractory ovarian cancer. Gynecol Oncol 12: 64?67
5. Comis RL (1976) DTIC (NSC-45388) in malignant melanoma: a perspective. Cancer Treat Rep 60: 165?176